Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atherosclerotic Cardiovascular Disease With Dyslipidemia”

133 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 133 results

Post-approval studies (Phase 4)Study completedNCT00079638
What this trial is testing

Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL

Who this might be right for
DyslipidemiaCoronary Heart DiseaseAtherosclerosis+2 more
Kos Pharmaceuticals 300
Not applicableActive Not RecruitingNCT05758779
What this trial is testing

The Danish Familial Hypercholesterolemia Organized Coronary Screening Trial

Who this might be right for
Familial HypercholesterolemiaAtherosclerosis
Odense University Hospital 100
Not applicableEnded earlyNCT05629767
What this trial is testing

Tracking of Lipid Lowering Therapy in Jordan

Who this might be right for
DyslipidemiasAtherosclerotic Cardiovascular Disease
Jordan Collaborating Cardiology Group 1,000
Not applicableUnknownNCT05624658
What this trial is testing

Effect of Combined Lipid-lowering Therapy on Atherosclerotic Plaque Vulnerability in Patients With ACS

Who this might be right for
Dyslipidemias
Samara Regional Cardiology Dispensary 200
Not applicableStudy completedNCT05362903
What this trial is testing

A Non-interventional Implementation Study to Evaluate Treatment With Inclisiran (Leqvio®) and Other Lipid Lowering Treatments in a Real-world Setting

Who this might be right for
Hypercholesterolemia
Novartis Pharmaceuticals 1,868
Not applicableStudy completedNCT06507852
What this trial is testing

A Real-world Study of Inclisiran Adherence, Treatment Patterns, Patient Characteristics, and Effectiveness in ASCVD Patients With Hypercholesterolemia, ASCVD-risk Equivalent Patients With Hypercholesterolemia and Familial Hypercholesterolemia

Who this might be right for
Atherosclerotic Cardiovascular DiseaseHypercholesterolemia
Novartis 95
Post-approval studies (Phase 4)Looking for participantsNCT06501443
What this trial is testing

LATAM LOWERS LDL-C

Who this might be right for
Hypercholesterolaemia
Novartis Pharmaceuticals 520
Large-scale testing (Phase 3)Active Not RecruitingNCT04765657
What this trial is testing

Study of Efficacy and Safety of Inclisiran in Asian Participants With Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD High Risk and Elevated Low Density Lipoprotein Cholesterol (LDL-C)

Who this might be right for
Hypercholesterolemia
Novartis Pharmaceuticals 345
Not applicableStudy completedNCT00536796
What this trial is testing

Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets

Who this might be right for
HyperlipidemiasAtherosclerosisCoronary Heart Disease+3 more
AstraZeneca 1,096
Post-approval studies (Phase 4)Study completedNCT00700037
What this trial is testing

Change in Plaque Characteristics With Atorvastatin

Who this might be right for
Acute Coronary SyndromeAtherosclerosisDyslipidemia
Wakayama Medical University 70
Post-approval studies (Phase 4)Looking for participantsNCT07581808
What this trial is testing

Dual PCSK9 Inhibition With Inclisiran and Alirocumab in Secondary Prevention

Who this might be right for
HypercholesterolemiaAtherosclerotic Cardiovascular Disease (ASCVD)
University Medical Centre Ljubljana 60
Post-approval studies (Phase 4)Study completedNCT02422927
What this trial is testing

Nutraceutical Combination in Patients With Low-grade Systemic Inflammation

Who this might be right for
AtherosclerosisInflammationHypercholesterolemia
University Of Perugia 100
Testing effectiveness (Phase 2)Study completedNCT05563246
What this trial is testing

LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

Who this might be right for
Lipoprotein Disorder
Eli Lilly and Company 233
Large-scale testing (Phase 3)Study completedNCT05610280
What this trial is testing

Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia

Who this might be right for
HypertriglyceridemiaCardiovascular DiseasesAtherosclerosis
Ionis Pharmaceuticals, Inc. 1,478
Testing effectiveness (Phase 2)Study completedNCT05266586
What this trial is testing

Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy

Who this might be right for
DyslipidemiasHigh CholesterolHypercholesterolemia
NewAmsterdam Pharma 119
Not applicableLooking for participantsNCT07447648
What this trial is testing

Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque Volumes Measured by Coronary Computed Tomography Angiography (CCTA) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)

Who this might be right for
Homozygous Familial Hypercholesterolemia (HoFH)Coronary Computed Tomography Angiography
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi) 52
Post-approval studies (Phase 4)UnknownNCT01382277
What this trial is testing

Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume

Who this might be right for
HyperlipidemiaCoronary Artery Disease
Peking University First Hospital 600
Large-scale testing (Phase 3)Study completedNCT02666664
What this trial is testing

Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)

Who this might be right for
HypercholesterolemiaAtherosclerotic Cardiovascular Diseases
Esperion Therapeutics, Inc. 2,230
Not applicableLooking for participantsNCT05705804
What this trial is testing

Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial

Who this might be right for
DyslipidemiasAtherosclerotic Cardiovascular Disease
Yonsei University 250
Large-scale testing (Phase 3)Study completedNCT01516541
What this trial is testing

Dalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular Disease

Who this might be right for
Cardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD)
Hoffmann-La Roche 2,220
Next Page